$1.18 EPS Expected for CME Group Inc. (CME) This Quarter
Analysts expect CME Group Inc. (NASDAQ:CME) to post earnings per share of $1.18 for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for CME Group’s earnings. The highest EPS estimate is $1.25 and the lowest is $1.13. CME Group reported earnings per share of $1.05 during the same quarter last year, which suggests a positive year-over-year growth rate of 12.4%. The company is scheduled to issue its next quarterly earnings report on Thursday, October 26th.
On average, analysts expect that CME Group will report full year earnings of $4.85 per share for the current fiscal year, with EPS estimates ranging from $4.78 to $4.98. For the next financial year, analysts forecast that the company will report earnings of $5.31 per share, with EPS estimates ranging from $5.10 to $5.49. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for CME Group.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925.00 million during the quarter, compared to analysts’ expectations of $931.05 million. During the same period in the prior year, the company earned $1.14 EPS. CME Group’s revenue was up 2.1% compared to the same quarter last year.
Several analysts have weighed in on the stock. Barclays PLC assumed coverage on shares of CME Group in a research note on Friday. They issued an “overweight” rating and a $139.00 price target for the company. UBS AG reissued a “buy” rating and issued a $135.00 price target (up from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Keefe, Bruyette & Woods reissued a “hold” rating and issued a $127.00 price target on shares of CME Group in a research note on Friday, August 18th. Finally, Royal Bank Of Canada set a $135.00 price target on shares of CME Group and gave the stock a “buy” rating in a research note on Tuesday, August 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $132.56.
COPYRIGHT VIOLATION WARNING: “$1.18 EPS Expected for CME Group Inc. (CME) This Quarter” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/09/12/1-18-eps-expected-for-cme-group-inc-cme-this-quarter.html.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $124.50, for a total transaction of $311,250.00. Following the completion of the transaction, the chief financial officer now directly owns 38,495 shares of the company’s stock, valued at $4,792,627.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Kathleen M. Cronin sold 8,125 shares of the company’s stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total transaction of $1,034,718.75. Following the transaction, the insider now directly owns 38,174 shares of the company’s stock, valued at $4,861,458.90. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 55,619 shares of company stock valued at $6,959,604. Insiders own 0.57% of the company’s stock.
Several large investors have recently modified their holdings of CME. Fiduciary Trust Co. bought a new position in shares of CME Group during the second quarter valued at about $105,000. Quadrant Capital Group LLC raised its stake in shares of CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after acquiring an additional 113 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of CME Group by 4.1% during the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock valued at $128,000 after acquiring an additional 43 shares during the last quarter. San Francisco Sentry Investment Group CA bought a new position in shares of CME Group during the second quarter valued at about $129,000. Finally, Whittier Trust Co. raised its stake in shares of CME Group by 2.6% during the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 27 shares during the last quarter. 82.67% of the stock is owned by hedge funds and other institutional investors.
Shares of CME Group (NASDAQ:CME) traded up 0.67% on Tuesday, hitting $129.66. The stock had a trading volume of 235,691 shares. The company has a market capitalization of $44.07 billion, a PE ratio of 26.47 and a beta of 0.72. The firm has a 50-day moving average of $124.96 and a 200 day moving average of $121.76. CME Group has a 1-year low of $98.95 and a 1-year high of $130.15.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 2.05%. The ex-dividend date is Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is 53.99%.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.